News
New advances in the characterization of the minority disease Limfangioleiomyomatosis
A team from IDIBELL and the ICO, through gene and protein expression analysis of the disease, has determined the biological traits that would explain the high heterogeneity and molecular similarities with cancer.
IDIBELL’s Innovation Unit receives the UNE 166002:2014 certification
The certification corroborates the conformity of the innovation management system according to the UNE 166002:2014 standard and certifies that IDIBELL is able to generate and manage innovation projects, systematize R+D+I activities and ensure that they are carried out effectively and efficiently.
Identified key alteration in the genes involved in the development of Cornelia de Lange syndrome
A study identifies the molecular basis of this rare disease, which causes extremities abnormalities and growth delay.
The immunological imprinting condition the response to SARS-CoV-2
A study by IDIBELL, Bellvitge Hospital, and the Icahn School of Medicine at Mount Sinai has shown for the first time that pre-existing immunity against other coronaviruses influences a possible immunity against SARS-CoV-2
Described two new variants of the TLR7 gene associated with severe COVID-19 in young and healthy men
The sequencing of the TLR7 gene in 14 young men with no medical history reveals the presence of two genetic variants that affect the immune response.
New advances in the understanding of the pathophysiology of megalencephalic leukoencephalopathy (MLC) minority brain disease
Two recent articles with the participation of a research group from IDIBELL, the University of Barcelona, and CIBERER describe different protein interactions of MLC1 and GlialCAM that could regulate neuronal development and activity.
IDIBELL and ICO participate in the discovery of a weakness that could be used to treat defective cancers for SMARCA4
The study suggests that tumors with a genetically inactivated form of the chromatin remodeling protein SMARCA4 are highly sensitive to inhibitors of the KDM6 family of histone demethylases.
Vocal music boosts the recovery of language functions after stroke
Listening to vocal music is a simple and cost-efficient way of promoting recovery and brain health after a stroke.
Discovered a new strategy to fight the metastatic melanoma
It has shown that the combination of chemotherapy with a BRAF oncogene inhibitor effectively treats this disease. This alternative opens the door to offer a new approach to patients affected by this type of tumor, which does not have a curative treatment in the more advanced stages or those with relapse.